Moderna to supply 100 to 125 million COVID-19 vaccine doses globally in first quarter

By: 4 years ago

Vials of coronavirus vaccine and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. (Reuters)

Moderna Inc said on Thursday it expects to have between 100 million and 125 million doses of its COVID-19 vaccine available globally in the first quarter of 2021.

The company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25 million outside the country.